SUBSCRIBERS

Endofotonics raises S$12m in Series B funding, led by Singapore Medical Group

Published Fri, May 29, 2020 · 09:50 PM

Singapore

CANCER diagnostic company Endofotonics on Friday said it has raised S$12 million in a Series B round led by executives from locally listed healthcare company Singapore Medical Group.

The additional funding will be used to drive commercialisation of its early gastric cancer detection system in the Asia-Pacific, and to expand the coverage of its cancer detection technology to other organs.

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here